SAB Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LMR PARTNERS LLP | 11/07/2024 | 539,588 | $19,425 | 100.00% | 5.83% |
| HB WEALTH MANAGEMENT, LLC | 10/15/2024 | 310,000 | $11,160 | 100.00% | 3.35% |
| MORGAN STANLEY | 11/14/2024 | 146,439 | $5,272 | 0.00% | 1.58% |
| YAKIRA CAPITAL MANAGEMENT, INC. | 11/13/2024 | 108,485 | $3,906 | 0.00% | 1.17% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 62,500 | $2,250 | 0.00% | 0.68% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 23,258 | $837 | 0.00% | 0.25% |
| WOLVERINE ASSET MANAGEMENT LLC | 11/04/2024 | 15,519 | $558 | 1.31% | 0.17% |
| WALLEYE TRADING LLC | 11/14/2024 | 15,505 | $558 | 0.00% | 0.17% |
| NEWEDGE ADVISORS, LLC | 11/14/2024 | 1,072 | $39 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 48 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| LMR PARTNERS LLP | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SHAOLIN CAPITAL MANAGEMENT LLC | 11/18/2024 | 0 | $0 | -100.00% | 0.00% |
SAB Biotherapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:
MORGAN STANLEY: 146,439
Yakira Capital Management, Inc.: 108,485
Walleye Capital LLC: 23,258
WOLVERINE ASSET MANAGEMENT LLC: 15,519
Walleye Trading LLC: 15,505
NewEdge Advisors, LLC: 1,072
6.70% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 310,326 shares in the last 24 months. This purchase volume represents approximately $24,826 in transactions.